Overview of investigations into pulmonary hemorrhage among infants in Cleveland, Ohio

Environmental Health Perspectives

Volumn 107, Issue SUPPL. 3, 1999, Pages 495-499

  Dearborn, Dorr G ^a   Yike, Iwona ^a   Sorenson, W G ^b   Miller, Martha J ^a   Etzel, Ruth A ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Environmental tobacco smoke; Idiopathic pulmonary hemosiderosis; Indoor mold; Pulmonary hemorrhage; Satratoxins; Stachybotrys chartarum; Sudden infant death syndrome; Toxigenic fungi; Trichothecenes

Indexed keywords

MYCOTOXIN; TOBACCO SMOKE;

CLINICAL ARTICLE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; FEMALE; FUNGUS; HUMAN; HYPHOMYCETES; INFANT; LUNG HEMORRHAGE; LUNG HEMOSIDEROSIS; MALE; MORTALITY; NEGRO; PRIORITY JOURNAL; SUDDEN INFANT DEATH SYNDROME;

EID: 0032765721     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.99107s3495     Document Type: Conference Paper

References (51)

1. CDC. Acute pulmonary hemorrhage/hemosiderosis among infants - Cleveland, January 1993-November 1994. Morb Mortal Wkly Rep 43:881-883 (1994).
2. CDC. Update: pulmonary hemorrhage/hemosiderosis among infants-Cleveland, Ohio, 1993-1996. Morb Mortal Wkly Rep 46:33-35 (1997).
3. Montana E, Etzel RA, Allan TM, Horgan TE, Dearborn DG. Environmental risk factors associated with pediatric idiopathic pulmonary hemosiderosis in a Cleveland community. Pediatrics 99(1) (http://www.pediatrics.org/cgi/ content/full/99/1/e5) (1997).
4. Etzel R., Montana E, Sorenson WG, Kullman GJ, Allan TM, Dearborn DG. Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med 152:757-762 (1998).
5. Etzel RA, Dearborn DG. Unpublished data.
6. Kjellman B, Elinder G, Garwicz S, Svan H. Idiopathic pulmonary haemosiderosis in Swedish children. Acta Paediatr Scand 73:584-588 (1984).
7. Ohga S, Takahashi K, Miyazaki S, Kato H, Ueda K. Idiopathic pulmonary haemosiderosis in Japan: 39 possible cases from a survey questionnaire. Eur J Pediatr 154:994-995 (1995).
8. Heiner DC, Sears JW, Kniker WT. Multiple precipitins to cow's milk in chronic respiratory disease. Am J Dis Child 103:634-654 (1962).
9. Levy J, Wilmott R. Pulmonary hemosiderosis. In: Pediatric Respiratory Disease: Diagnosis and Treatment (Hilman BC, ed). Philadelphia:WB Saunders, 1993;543-549.
10. Cassimos CD, Chryssanthopoulos C, Panagiotidou C. Epidemiologic observations in idiopathic pulmonary hemosiderosis. J Pediatr 102:698-702 (1983).
11. Boat TF. Pulmonary hemorrhage and hemoptysis. In: Kendig's Disorders of the Respiratory Tract in Children. 6th ed (Chernick V, Boat TF, eds). Philadelphia:WB Saunders, 1998; 623-633.
12. Rosenstein BJ. Hemoptysis. In: Pediatric Respiratory Disease: Diagnosis and Treatment (Hilman BC, ed). Philadelphia:WB Saunders, 1993;533-543.
13. Sherman JM, Winnie G, Thomassen MJ, Abdul-Karim FW, Boat TF. Time course of hemosiderin production ard clearance by human pulmonary macrophages. Chest 86:409-411 (1984).
14. Sherman JM. Personal communication.
15. Jarvis BB, Sorenson WG, Hintikka E-L, Nikulin M, Zhou Y, Jiang J, Wang S, Hinkley S, Etzel RA, Dearborn DG. Studies of toxin production by isolates of Stachybotrys chartarum and Memnoniella echinata isolated during a study of pulmonary hemosiderosis in infants. Appl Environ Microbiol 64:3620-3625 (1998).
16. Yike I, Allan T, Sorenson WG, Dearborn DG. Highly sensitive protein translation assay for trichothecene toxicity in airborne particulates: comparison with cytotoxicity assays. Appl Environ Microbiol 65:88-94 (1999).
17. Census tract data provided by Northern Ohio Data and Information Service, Levin College of Urban Affairs, Cleveland State University, Cleveland, OH.
18. Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 319:1112-1117 (1988).
19. Jong SC, Davis EE. Contribution to the knowledge of Stachybotrys and Memnoniella in culture. Mycotaxon 3:409-485 (1976).
20. Hintikka EL. Human Stachybotrytoxicosis. In: Mycotoxigenic Fungi, Mycotoxins, Mycotoxicoses (Wyllie TD, Morehouse LG, eds). New York:Marcel Dekker, 1978;87-39.
21. Sorenson WG, Lewis DM. Organic dust toxic syndrome. In: The Mycota (Esser K, Lemke PA, eds). Vol VII: Animal and Human Relationships. Berlin:Springer-Verlag, 1996:159-172.
22. Rylander R. Symptoms and mechanisms of inflammation of the lung. Am J Ind Med 25:19-23 (1994).
23. Jarvis BB, Salemme J, Morais A. Stachybotrys toxins 1. Natural Toxins 3:10-16 (1995).
24. Bubien JK, Lundeen G, Templeton C, Woods WT. Effects on the circulatory system. In: Trichothecene Mycotoxins: Pathophysiologic Effects, Vol 2 (Beasley VR, ed). Boca Raton, FL:CRC Press, 1989;91-111.
25. Pestka JJ, Bondy GS. Immunotoxic effects of mycotoxins. In: Mycotoxins in Grain (Miller JD, Trenholm HL, eds). St. Paul, MN:Eagan Press, 1994;339-358.
26. Prelusky DB, Trenholm HL. The efficacy of various classes of anti-emetics in preventing deoxynivalenol-induced vomiting in swine. Natural Toxins 1:296-302 (1993).
27. Prelusky DB, Rotter BA, Rotter RG. Toxicology of mycotoxins. In: Mycotoxins in Grain (Miller JD, Trenholm HL, eds). St. Paul, MN:Eagan Press, 1994;359-404.
28. Kuiper-Goodman T. Prevention of human mycotoxicosis through risk assessment and risk management. In: Mycotoxins in Grain (Miller JD, Trenholm HL, eds). St. Paul, MN:Eagan Press, 1994;439-470.
29. Creasia DA, Lambert RJ. Acute respiratory tract toxicity of the trichothecene mycotoxin T-2 toxin. In: Trichothecene Mycotoxins: Pathophysiologic Effects, Vol 1 (Beasley VR, ed). Boca Raton, FL:CRC Press, 1989;161-170.
30. Feinberg B, MacLaughlin CS. Biochemical mechanism of action of trichothecene mycotoxins. In: Trichothecene Mycotoxins: Pathophysiologic Effects, Vol 1 (Beasley VR, ed). Boca Raton, FL:CRC Press, 1989;27-36.
31. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen E Jr. Biological warfare: a historical perspective. JAMA 278:412-417 (1997).
32. Zilinskas RA. Iraq's biological weapons: the past as future? JAMA 278:418-424 (1997).
33. Miyazaki W, Tamaoka H, Shinohara M, Kaise H, Izawa T, Nakano Y, Kinoshita T, Hong K, Inoue K. A complement inhibitor produced by Stachybotrys. sp.K-76, a new species of fungi imperfecti. Microbiol Immunol 24:1091-1108 (1980).
34. Sakamoto K, Tsujii E, Miyauchi M, Nakanishi T, Yamashita M, Shigematsu N, Tada T, Izumi S, Okuhara M. FR901459, a novel immunosuppressant isolated from Stachybotrys chartarum (atra) no. 19392. J Antibiot 46:1788-1798 (1993).
35. Nakamura M, Ito Y, Ogawa K, Michisuji Y, Sato S-I, Takada M, Hayashi M, Yaginuma S, Yamamoto S. Stachybocins, novel endothelin receptor antagonists, produced by Stachybotrys sp. M6222 I. Taxonomy, fermentation, isolation, and characterization. J Antibiot 48:1389-1395 (1995).
36. Fung D, Clark R, Williams S. Stachybotrys, a mycotoxin-producing fungus of increasing toxicologic importance. J Toxicol Clin Toxicol 36:79-86 (1998).
37. Croft WA, Jarvis BB, Yatawara SC. Airborne outbreak of trichothecene toxicosis. Atmos Environ 20:549-552 (1986).
38. Johanning E. Health problems related to fungal exposure: the example of toxigenic Stachybotrys chartarum (atra). In: Fungi and Bacteria in Indoor Air Environments (Johanning E, Yang CS, eds). Latham, NY:Eastern New York Occupational Health Program, 1995;201-208.
39. Hodgson MJ, Morey P, Leung W-Y, Morrow L, Miller JD, Jarvis BB, Robbins H, Halsey JF, Storey E. Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J Occup Environ Med 40:241-249 (1998).
40. Johanning E, Biagini R, Hull D, Morey P, Jarvis B, Landsbergis P. Health and immunology study following exposure to toxigenic fungi (Stachybotrys chartarum) in a water-damaged office environment. Int Arch Occup Environ Health 68:207-218 (1996).
41. Sorenson EG, Frazer DG, Jarvis BB, Simpson J, Robinson VA. Trichothecene mycotoxins in aerosolized conidia of Stachybotrys atra. Appl Environ Microbiol 53:1370-1375 (1987).
42. Canada Mortgage and Housing Corporation. Moldy Houses: Why They Are and Why We Care. Ottawa, Ontario:Canada Mortgage and Housing Corporation, 1996.
43. Miller JD, Laflamme AM, Sobol Y, Lafontaine P, Greenhalph R. Fungi and fungal products in some Canadian house. Int Biodeterior 24:103-120 (1988).
44. Kozak PS, Gallup J. Endogenous mold exposure: environmental risk to atopic and non-atopic patients. In: Indoor Air and Human Health (Gammage RV, Kay SV, eds). Chelsea, MI:Lewis Publishers, 1989;149-167.
45. Nikulin M, Reijula K, Jarvis BB, Hintikka E-L. Experimental lung mycotoxicosis in mice induced by Stachybotrys atra. Int J Exp Pathol 77:213-218 (1996).
46. Nikulin M, Reijula K, Jarvis BB, Veijalainen P, and Hintikka E-L. Effects of intranasal exposure to spores of Stachybotrys atra in mice. Fundam Appl Toxicol 35:182-188 (1997).
47. Sorenson WG, Gerberick GF, Lewis DM, Castranova V. Toxicity of mycotoxins for the rat pulmonary macrophage in vitro. Environ Health Perspect 66:45-53 (1986).
48. Thurman JD, Creasia DA, Trotter RW. Mycotoxicosis caused by aerosolized T-2 toxin administered to female mice. Am J Vet Res 49:1928-1931 (1988).
49. West JB, Mathieu-Costello O. Vulnerability of pulmonary capillaries in heart disease. Circulation 92:622-631 (1995).
50. Huggins JP, Pelton JT, Miller RC. The structure and specificity of endothelin receptors: their importance in physiology and medicine. Pharmacol Ther 59:55-123 (1993).
51. American Academy of Pediatrics. Toxic effects of indoor molds. Pediatrics 101:712-714 (1998).